1 1347 180 HYPOXIA IN CNS PATHOLOGIES: EMERGING ROLE OF MIRNA-BASED NEUROTHERAPEUTICS AND YOGA BASED ALTERNATIVE THERAPIES. CELLULAR RESPIRATION IS A VITAL PROCESS FOR THE EXISTENCE OF LIFE. ANY CONDITION THAT RESULTS IN DEPRIVATION OF OXYGEN (ALSO TERMED AS HYPOXIA) MAY EVENTUALLY LEAD TO DELETERIOUS EFFECTS ON THE FUNCTIONING OF TISSUES. BRAIN BEING THE HIGHEST CONSUMER OF OXYGEN IS PRONE TO INCREASED RISK OF HYPOXIA-INDUCED NEUROLOGICAL INSULTS. THIS IN TURN HAS BEEN ASSOCIATED WITH MANY DISEASES OF CENTRAL NERVOUS SYSTEM (CNS) SUCH AS STROKE, ALZHEIMER'S, ENCEPHALOPATHY ETC. ALTHOUGH SEVERAL STUDIES HAVE INVESTIGATED THE PATHOPHYSIOLOGICAL MECHANISMS UNDERLYING ISCHEMIC/HYPOXIC CNS DISEASES, THE KNOWLEDGE ABOUT PROTECTIVE THERAPEUTIC STRATEGIES TO AMELIORATE THE AFFECTED NEURONAL CELLS IS MEAGER. THIS HAS AUGMENTED THE NEED TO IMPROVE OUR UNDERSTANDING OF THE HYPOXIC AND ISCHEMIC EVENTS OCCURRING IN THE BRAIN AND IDENTIFY NOVEL AND ALTERNATE TREATMENT MODALITIES FOR SUCH INSULTS. MICRORNA (MIRNAS), SMALL NON-CODING RNA MOLECULES, HAVE RECENTLY EMERGED AS POTENTIAL NEUROPROTECTIVE AGENTS AS WELL AS TARGETS, UNDER HYPOXIC CONDITIONS. THESE 18-22 NUCLEOTIDE LONG RNA MOLECULES ARE PROFUSELY PRESENT IN BRAIN AND OTHER ORGANS AND FUNCTION AS GENE REGULATORS BY CLEAVING AND SILENCING THE GENE EXPRESSION. IN BRAIN, THESE ARE KNOWN TO BE INVOLVED IN NEURONAL DIFFERENTIATION AND PLASTICITY. THEREFORE, TARGETING MIRNA EXPRESSION REPRESENTS A NOVEL THERAPEUTIC APPROACH TO INTERCEDE AGAINST HYPOXIC AND ISCHEMIC BRAIN INJURY. IN THE FIRST PART OF THIS REVIEW, WE WILL DISCUSS THE NEUROPHYSIOLOGICAL CHANGES CAUSED AS A RESULT OF HYPOXIA, FOLLOWED BY THE CONTRIBUTION OF HYPOXIA IN THE NEURODEGENERATIVE DISEASES. SECONDLY, WE WILL PROVIDE RECENT UPDATES AND INSIGHTS INTO THE ROLES OF MIRNA IN THE REGULATION OF GENES IN OXYGEN AND GLUCOSE DEPRIVED BRAIN IN ASSOCIATION WITH CIRCADIAN RHYTHMS AND HOW THESE CAN BE TARGETED AS NEUROPROTECTIVE AGENTS FOR CNS INJURIES. FINALLY, WE WILL EMPHASIZE ON ALTERNATE BREATHING OR YOGIC INTERVENTIONS TO OVERCOME THE HYPOXIA ASSOCIATED ANOMALIES THAT COULD ULTIMATELY LEAD TO IMPROVEMENT IN CEREBRAL PERFUSION. 2017 2 384 30 BENEFICIAL EFFECTS OF YOGA LIFESTYLE ON REVERSIBILITY OF ISCHAEMIC HEART DISEASE: CARING HEART PROJECT OF INTERNATIONAL BOARD OF YOGA. OBJECTIVES: YOGA BASED LIFESTYLE MODIFICATIONS HAVE BEEN EARLIER SHOWN TO BE BENEFICIAL IN CORONARY ARTERY DISEASE IN A SMALL NUMBER OF PATIENTS. WE EVALUATED THE ROLE OF LIFESTYLE MODIFICATION BASED ON YOGA TECHNIQUES, STRESS MANAGEMENT AND DIETARY MODIFICATIONS IN RETARDATION OF CORONARY ARTERY DISEASE. METHODS: THIS PROSPECTIVE, CONTROLLED, OPEN TRIAL INCLUDED ANGIOGRAPHICALLY PROVEN CORONARY ARTERY DISEASE PATIENTS (71 PATIENTS IN STUDY GROUP AND 42 PATIENTS IN CONTROL GROUP). THEY WERE ASSESSED CLINICALLY, BY BIOCHEMICAL PARAMETERS, STRESS MYOCARDIAL PERFUSION AND FUNCTION STUDIES AND CORONARY ANGIOGRAPHY AND ON PSYCHOLOGICAL PARAMETERS. THE STUDY GROUP PATIENTS WERE GIVEN A FAMILY BASED YOGA PROGRAMME WHICH INCLUDED, CONTROL OF RISK FACTORS, DIETARY MODIFICATIONS AND STRESS MANAGEMENT FOR A PERIOD OF ONE YEAR. THE PATIENTS WERE ASSESSED AT BASELINE, AT FREQUENT INTERVALS AND AT THE END OF ONE YEAR. RESULTS: AT THE END OF ONE YEAR OF YOGA TRAINING, STATISTICAL SIGNIFICANT CHANGES (P<0.05) WERE FOUND IN SERUM TOTAL CHOLESTEROL (REDUCTION BY 23.3% IN STUDY GROUP PATIENTS AS COMPARED TO 4.4% IN CONTROLS); SERUM LDL CHOLESTEROL (REDUCTION OF 26% IN STUDY GROUP PATIENTS AS COMPARED TO 2.6% IN THE CONTROL GROUP), REGRESSION OF DISEASE (43.7% OF STUDY GROUP PATIENTS V/S 31% CONTROL GROUP ON MPI AND 70.4% OF STUDY GROUP V/S 28% OF CONTROL GROUP ON ANGIOGRAPHY) ARREST OF PROGRESSION (46.5% STUDY GROUP V/S 33.3% CONTROL GROUP ON MPI) AND PROGRESSION (9.9% OF STUDY GROUP VS 35.7% OF CONTROLS ON MPI, 29.6% OF STUDY GROUP V/S 60.0% OF CONTROLS ON ANGIOGRAPHY). AT THE END OF THE STUDY IMPROVEMENT IN ANXIETY SCORES WAS CONCORDANT WITH THE IMPROVEMENT SEEN IN THE MPI. NO UNTOWARD EFFECTS OF THE THERAPY WERE OBSERVED. CONCLUSION: YOGA BASED LIFESTYLE MODIFICATIONS HELP IN REGRESSION OF CORONARY LESIONS AND IN IMPROVING MYOCARDIAL PERFUSION. THIS IS TRANSLATED INTO CLINICAL BENEFITS AND SYMPTOMATIC IMPROVEMENT. 2004 3 1904 31 RETARDATION OF CORONARY ATHEROSCLEROSIS WITH YOGA LIFESTYLE INTERVENTION. BACKGROUND: YOGA HAS POTENTIAL FOR BENEFIT FOR PATIENTS WITH CORONARY ARTERY DISEASE THOUGH OBJECTIVE, ANGIOGRAPHIC STUDIES ARE LACKING. MATERIAL AND METHODS: WE EVALUATED POSSIBLE ROLE OF LIFESTYLE MODIFICATION INCORPORATING YOGA, ON RETARDATION OF CORONARY ATHEROSCLEROTIC DISEASE. IN THIS PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL, 42 MEN WITH ANGIOGRAPHICALLY PROVEN CORONARY ARTERY DISEASE (CAD) WERE RANDOMIZED TO CONTROL (N = 21) AND YOGA INTERVENTION GROUP (N = 21) AND WERE FOLLOWED FOR ONE YEAR. THE ACTIVE GROUP WAS TREATED WITH A USER-FRIENDLY PROGRAM CONSISTING OF YOGA, CONTROL OF RISK FACTORS, DIET CONTROL AND MODERATE AEROBIC EXERCISE. THE CONTROL GROUP WAS MANAGED BY CONVENTIONAL METHODS I.E. RISK FACTOR CONTROL AND AMERICAN HEART ASSOCIATION STEP I DIET. RESULTS: AT ONE YEAR, THE YOGA GROUPS SHOWED SIGNIFICANT REDUCTION IN NUMBER OF ANGINAL EPISODES PER WEEK, IMPROVED EXERCISE CAPACITY AND DECREASE IN BODY WEIGHT. SERUM TOTAL CHOLESTEROL, LDL CHOLESTEROL AND TRIGLYCERIDE LEVELS ALSO SHOWED GREATER REDUCTIONS AS COMPARED WITH CONTROL GROUP. REVASCULARISATION PROCEDURES (CORONARY ANGIOPLASTY OR BYPASS SURGERY) WERE LESS FREQUENTLY REQUIRED IN THE YOGA GROUP (ONE VERSUS EIGHT PATIENTS; RELATIVE RISK = 5.45; P = 0.01). CORONARY ANGIOGRAPHY REPEATED AT ONE YEAR SHOWED THAT SIGNIFICANTLY MORE LESIONS REGRESSED (20% VERSUS 2%) AND LESS LESIONS PROGRESSED (5% VERSUS 37%) IN THE YOGA GROUP (CHI-SQUARE = 24.9; P < 0.0001). THE COMPLIANCE TO THE TOTAL PROGRAM WAS EXCELLENT AND NO SIDE EFFECTS WERE OBSERVED. CONCLUSION: YOGA LIFESTYLE INTERVENTION RETARDS PROGRESSION AND INCREASES REGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH SEVERE CORONARY ARTERY DISEASE. IT ALSO IMPROVES SYMPTOMATIC STATUS, FUNCTIONAL CLASS AND RISK FACTOR PROFILE. 2000 4 1639 41 MODULATION OF IMMUNE RESPONSES IN STRESS BY YOGA. STRESS IS A CONSTANT FACTOR IN TODAY'S FASTPACED LIFE THAT CAN JEOPARDIZE OUR HEALTH IF LEFT UNCHECKED. IT IS ONLY IN THE LAST HALF CENTURY THAT THE ROLE OF STRESS IN EVERY AILMENT FROM THE COMMON COLD TO AIDS HAS BEEN EMPHASIZED, AND THE MECHANISMS INVOLVED IN THIS PROCESS HAVE BEEN STUDIED. STRESS INFLUENCES THE IMMUNE RESPONSE PRESUMABLY THROUGH THE ACTIVATION OF THE HYPOTHALAMIC-PITUITARY ADRENAL AXIS, HYPOTHALAMIC PITUITARY-GONADAL AXIS, AND THE SYMPATHETIC-ADRENAL-MEDULLARY SYSTEM. VARIOUS NEUROTRANSMITTERS, NEUROPEPTIDES, HORMONES, AND CYTOKINES MEDIATE THESE COMPLEX BIDIRECTIONAL INTERACTIONS BETWEEN THE CENTRAL NERVOUS SYSTEM (CNS) AND THE IMMUNE SYSTEM. THE EFFECTS OF STRESS ON THE IMMUNE RESPONSES RESULT IN ALTERATIONS IN THE NUMBER OF IMMUNE CELLS AND CYTOKINE DYSREGULATION. VARIOUS STRESS MANAGEMENT STRATEGIES SUCH AS MEDITATION, YOGA, HYPNOSIS, AND MUSCLE RELAXATION HAVE BEEN SHOWN TO REDUCE THE PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF STRESS IN CANCERS AND HIV INFECTION. THIS REVIEW AIMS TO DISCUSS THE EFFECT OF STRESS ON THE IMMUNE SYSTEM AND EXAMINE HOW RELAXATION TECHNIQUES SUCH AS YOGA AND MEDITATION COULD REGULATE THE CYTOKINE LEVELS AND HENCE, THE IMMUNE RESPONSES DURING STRESS. 2008 5 2490 30 YOGA AS AN INTERVENTION TO MANAGE MULTIPLE SCLEROSIS SYMPTOMS. MULTIPLE SCLEROSIS (MS) IS AN AUTOIMMUNE, DEMYELINATING, INFLAMMATORY DISEASE OF CENTRAL NERVOUS SYSTEM (CNS) WHICH IS CHARACTERIZED BY SPASTICITY, FATIGUE, DEPRESSION, ANXIETY, BOWEL AND BLADDER DYSFUNCTION, IMPAIRED MOBILITY, COGNITIVE IMPAIRMENT ETC. AND AFFECTS APPROXIMATELY 2.5 MILLION PEOPLE WORLDWIDE. DISEASE MODIFYING THERAPIES FOR MS WHICH HELP IN PREVENTING ACCUMULATION OF LESIONS IN WHITE MATTER OF CNS ARE COSTLY AND HAVE SIGNIFICANT ADVERSE EFFECTS. THEREFORE, PATIENTS WITH MS ARE USING COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) AND YOGA IS ONE OF THE MOST POPULAR FORM OF CAM WHICH IS BEING USED IMMENSELY TO REDUCE OR OVERCOME THE SYMPTOMS OF MS. IN THE CURRENT REVIEW ATTEMPTED TO PRESENT THE POTENTIAL IMPACT OF YOGA PRACTICES ON REDUCING MS RELATED SYMPTOMS. 2020 6 450 43 CHANGES IN CIRCULATING MICRORNA AFTER RECUMBENT ISOMETRIC YOGA PRACTICE BY PATIENTS WITH MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: AN EXPLORATIVE PILOT STUDY. BACKGROUND: YOGA IS A REPRESENTATIVE MIND-BODY THERAPY. OUR PREVIOUS STUDIES HAVE DEMONSTRATED THAT ISOMETRIC YOGA (I.E. YOGA PROGRAMS THAT WE DEVELOPED SO INDIVIDUALS CAN PRACTICE YOGA POSES WITH A SELF-ADJUSTABLE ISOMETRIC LOAD) REDUCES THE FATIGUE OF PATIENTS WITH MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS); HOWEVER, THE UNDERLYING MECHANISMS REMAIN UNCLEAR. SEVERAL STUDIES HAVE SUGGESTED THAT THE MICRO-RIBONUCLEIC ACID (MIRNA) EXPRESSION OF ME/CFS PATIENTS IS DIFFERENT FROM THAT OF HEALTHY SUBJECTS. HOWEVER, IT HAS NOT TO DATE BEEN DETERMINED IF THE PRACTICE OF ISOMETRIC YOGA CAN AFFECT MIRNA EXPRESSION. THEREFORE, WE SOUGHT TO INVESTIGATE IF ISOMETRIC YOGA IS ASSOCIATED WITH CHANGES IN THE EXPRESSION LEVELS OF SERUM MIRNA OF PATIENTS WITH ME/CFS. METHODS: THE STUDY INCLUDED NINE PATIENTS WITH ME/CFS WHO FAILED TO SHOW SATISFACTORY IMPROVEMENT AFTER AT LEAST 6 MONTHS OF TREATMENT ADMINISTERED AT OUR HOSPITAL. PATIENTS PRACTICED RECUMBENT ISOMETRIC YOGA FOR 3 MONTHS; THEY MET WITH A YOGA INSTRUCTOR EVERY 2 TO 4 WEEKS AND PARTICIPATED IN DAILY IN-HOME SESSIONS. THE EFFECT OF RECUMBENT ISOMETRIC YOGA ON FATIGUE WAS ASSESSED BY COMPARING PRE- AND POST-INTERVENTION SCORES ON THE JAPANESE VERSION OF THE 11-ITEM CHALDER FATIGUE SCALE (CFQ 11). PATIENT BLOOD SAMPLES WERE DRAWN PRE- AND POST-INTERVENTION, JUST PRIOR TO PRACTICING RECUMBENT ISOMETRIC YOGA WITH AN INSTRUCTOR. THE SERUM WAS USED FOR MIRNA ARRAY ANALYSIS WITH KNOWN HUMAN MIRNAS. RESULTS: THE AVERAGE CFQ 11 SCORE DECREASED SIGNIFICANTLY (FROM 25.3 +/- 5.5 TO 17.0 +/- 5.8, P < 0.0001) AFTER PRACTICING RECUMBENT ISOMETRIC YOGA FOR 3 MONTHS. THE MIRNA MICROARRAY ANALYSIS REVEALED THAT FOUR MIRNAS WERE SIGNIFICANTLY UPREGULATED, AND 42 WERE DOWNREGULATED AFTER THE INTERVENTION PERIOD. CONCLUSIONS: THIS EXPLORATIVE PILOT STUDY IS THE FIRST TO DEMONSTRATE CHANGES IN THE SERUM LEVELS OF SEVERAL MIRNAS AFTER REGULAR PRACTICE OF RECUMBENT ISOMETRIC YOGA. THESE MIRNAS MIGHT REPRESENT BIOMARKERS FOR THE FATIGUE-RELIEVING EFFECTS OF ISOMETRIC YOGA OF PATIENTS WITH ME/CFS. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) 000023472. REGISTERED AUG 4, 2016. 2019 7 683 40 EFFECT OF AN 8-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON PSYCHO-NEURO-IMMUNE AXIS, DISEASE ACTIVITY, AND PERCEIVED QUALITY OF LIFE IN RHEUMATOID ARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. VARIOUS EXTERNAL STRESSORS AND ENVIRONMENTAL CHALLENGES LEAD TO THE PROVOCATION OF THE IMMUNE SYSTEM IN AUTOIMMUNE DISEASES LIKE RHEUMATOID ARTHRITIS (RA). THE INAPPROPRIATE IMMUNE RESPONSE FURTHER TRIGGERS THE CASCADE OF INFLAMMATORY CHANGES RESULTING IN PRECIPITATION OF SYMPTOMS AND HAMPERS QUALITY OF LIFE (QOL). THE UNDERLYING PSYCHO-SOMATIC COMPONENT OF THE DISEASE REQUIRES A HOLISTIC APPROACH TO ITS TREATMENT DIMENSION RATHER THAN THE USE OF PHARMACOTHERAPY. THE APPLICABILITY OF MIND-BODY INTERVENTIONS HAS BECOME ESSENTIAL IN TODAY'S FAST-PACED LIFE. YOGA, A MIND-BODY TECHNIQUE, ALTERS THE MIND'S CAPACITY TO FACILITATE SYSTEMIC FUNCTIONING AT MULTIPLE ORGAN SYSTEM LEVELS. HENCE, WE CONDUCTED THIS STUDY TO EVALUATE THE IMPACT OF 8 WEEKS OF A YOGA-BASED LIFESTYLE INTERVENTION (YBLI) ON PSYCHO-NEURO-IMMUNE MARKERS, GENE EXPRESSION PATTERNS, AND QOL IN RA PATIENTS ON ROUTINE MEDICAL THERAPY. A TOTAL OF 66 PATIENTS WERE RANDOMIZED INTO TWO GROUPS: YOGA GROUP OR NON-YOGA GROUP AND WERE ASSESSED FOR A PANEL OF INFLAMMATORY CYTOKINES (IL-6, IL-17A, TNF-ALPHA, AND TGF-BETA), MIND-BODY COMMUNICATIVE MARKERS (BDNF, DHEAS, BETA-ENDORPHIN, AND SIRTUIN) AND TRANSCRIPT LEVELS OF VARIOUS GENES (IL-6, TNF-ALPHA, NFKB1, TGF-BETA, AND CTLA4). WE ASSESSED DISEASE ACTIVITY AND QOL USING THE DAS28-ESR AND WHOQOL-BREF QUESTIONNAIRE, RESPECTIVELY. YOGA GROUP OBSERVED SIGNIFICANT IMPROVEMENTS IN THE LEVELS OF MARKERS, WHICH INFLUENCED THE PSYCHO-NEURO-IMMUNE AXIS (P < 0.001) WITH AN ESTIMATED EFFECT SIZE FROM SMALL TO MEDIUM RANGE. IN THE YOGA GROUP, THERE WAS A SIGNIFICANT REDUCTION IN DAS28-ESR (P < 0.001) AND IMPROVEMENT SEEN IN THE PHYSICAL HEALTH, PSYCHOLOGICAL, SOCIAL RELATIONSHIPS DOMAINS (P < 0.001) OF QOL, EXCEPT ENVIRONMENTAL (P > 0.05). THE YOGA GROUP SHOWED DOWNREGULATION OF IL-6, TNF-ALPHA, AND CTLA4 AND UPREGULATION OF TGF-BETA. THESE RESULTS SUGGEST THAT A DECREASE IN DISEASE ACTIVITY AFTER YOGA PRACTICE IS ASSOCIATED WITH A SIGNIFICANT REDUCTION IN INFLAMMATORY CYTOKINES, THE ELEVATION OF MIND-BODY COMMUNICATIVE MARKERS, AND NORMALIZATION OF VARIOUS TRANSCRIPT LEVELS, WHICH IMPROVED QOL. THUS THE ADOPTION OF YBLI IMPROVES CLINICAL OUTCOME IN RA, AND DECREASES SYSTEMIC INFLAMMATION BY ITS BENEFICIAL EFFECTS ON PSYCHO-NEURO-IMMUNE AXIS AND NORMALIZATION OF DYSREGULATED TRANSCRIPTS. THUS YBLI MAY BE USED FOR RA PATIENTS AS AN ADJUNCTIVE THERAPY. 2020 8 1927 39 ROLE OF YOGA IN CARDIAC DISEASE AND REHABILITATION. PURPOSE: CARDIOVASCULAR DISEASE CONTINUES TO BE THE LEADING CAUSE OF MORBIDITY AND MORTALITY AROUND THE WORLD. YOGA, A COMBINATION OF PHYSICAL POSTURES (ASANA), BREATHING EXERCISES (PRANAYAMA), AND MEDITATION (DHYANA), HAS GAINED INCREASING RECOGNITION AS A FORM OF MIND-BODY EXERCISE. IN THIS NARRATIVE REVIEW, WE INTENDED TO REVIEW THE EMERGING EVIDENCE ASSESSING THE PHYSIOLOGIC AND CLINICAL EFFECTS OF YOGA ON THE CARDIOVASCULAR SYSTEM AND THE POTENTIAL ROLE OF YOGA AS A COMPONENT OF COMPREHENSIVE CARDIAC REHABILITATION. METHODS: WE SEARCHED PUBMED, GOOGLE SCHOLAR, EMBASE, AND COCHRANE DATABASES FOR LITERATURE RELATED TO CARDIOVASCULAR EFFECTS OF YOGA FROM INCEPTION UP UNTIL 2017. RESULTS: YOGA HAS BEEN SHOWN TO HAVE FAVORABLE EFFECTS ON SYSTEMIC INFLAMMATION, STRESS, THE CARDIAC AUTONOMIC NERVOUS SYSTEM, AND TRADITIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS. CONCLUSIONS: YOGA HAS SHOWN PROMISE AS A USEFUL LIFESTYLE INTERVENTION THAT CAN BE INCORPORATED INTO CARDIOVASCULAR DISEASE MANAGEMENT ALGORITHMS. ALTHOUGH MANY INVESTIGATORS HAVE REPORTED THE CLINICAL BENEFITS OF YOGA IN REDUCING CARDIOVASCULAR EVENTS, MORBIDITY, AND MORTALITY, EVIDENCE SUPPORTING THESE CONCLUSIONS IS SOMEWHAT LIMITED, THEREBY EMPHASIZING THE NEED FOR LARGE, WELL-DESIGNED RANDOMIZED TRIALS THAT MINIMIZE BIAS AND METHODOLOGICAL DRAWBACKS. 2019 9 2013 31 SUDARSHAN KRIYA YOGA: A BREATH OF HOPE DURING COVID-19 PANDEMIC. IMPORTANT COUNTER MEASURES TO COMBAT AN INFECTIOUS DISEASE PANDEMIC INCLUDE VACCINATION, ANTIVIRAL THERAPY, AND IMMUNOMODULATION THERAPY. VACCINATIONS ARE DISEASE SPECIFIC AND MOREOVER STRAIN SPECIFIC, SO THE PROTECTION PROVIDED IS ALSO SPECIFIC AND LIMITED. ANTIVIRAL THERAPIES ARE COSTLY AND REQUIRE BULK PRODUCTION OF DRUGS, HENCE GLOBALLY THERE IS AN INCREASED INTEREST TOWARD LOW-RISK, COST-EFFECTIVE COMPLEMENTARY ALTERNATIVE THERAPIES, SUCH AS YOGA AND AYURVEDA TO TACKLE THE INFECTIOUS PANDEMIC, CORONAVIRUS DISEASE 2019 (COVID-19). THERE IS CLINICAL EVIDENCE AVAILABLE ON THE POTENTIAL COMPLEMENTARY ROLE OF YOGIC PRACTICES IN THE MANAGEMENT OF NONCOMMUNICABLE AND COMMUNICABLE DISEASES. VARIOUS ONLINE DATABASES WERE SEARCHED FOR ARTICLES PUBLISHED BETWEEN 2000 AND 2020. DATABASES EXPLORED WERE MEDLINE, EMBASE, INDIAN CITATION INDEX, PSYCINFO, INDEX MEDICUS FOR SOUTH-EAST ASIA REGION, AND GOOGLE SCHOLAR. ALL SEARCH RESULTS WERE SCREENED, AND ARTICLES RELATED TO KEYWORDS SUCH AS COVID-19, YOGA THERAPY, AND SUDARSHAN KRIYA YOGA (SKY) WERE SELECTED FOR DATA EXTRACTION. QUALITY OF THE STUDIES INCLUDED WAS EVALUATED ON THE BASIS OF THE CONSTRUCT VALIDITY, CONTENT VALIDITY, RELEVANCE, BIAS, CREDIBILITY RELATING TO INFORMATION, AND DATA SOURCES. SKY IS A UNIQUE YOGIC PRACTICE THAT INCLUDES SPECIFIC SEQUENTIAL BREATHING TECHNIQUES. IT BALANCES THE AUTONOMIC NERVOUS SYSTEM AND THUS CAN ALLEVIATE ANXIETY, ROUTINE STRESS, DEPRESSION, STRESS-RELATED MEDICAL DISORDERS, AND POSTTRAUMATIC STRESS. IT POTENTIATES NATURAL HOST IMMUNE DEFENSES THAT ARE ESSENTIAL TO TACKLE A PLETHORA OF MICROBIAL INFECTIONS. THIS NARRATIVE REVIEW ARTICLE PROVIDES AN OVERVIEW OF POTENTIAL THERAPEUTIC BENEFITS THAT SKY CAN OFFER TO THE POPULATION AT LARGE DURING THIS COVID-19 PANDEMIC. 2021 10 1698 28 PAIN-RELATED ENCEPHALIC REGIONS INFLUENCED BY YOGA MEDITATION: AN INTEGRATIVE REVIEW. INTRODUCTION: THE MECHANISMS UNDERLYING THE USE OF YOGA IN PAIN RELIEF ARE STILL UNCLEAR. THIS STUDY REVIEWED LITERATURE REPORTS ON ENCEPHALIC ACTIVITY RELATED TO ANALGESIA INDUCED BY YOGA MEDITATION PRACTICE. METHODS: THIS INTEGRATIVE REVIEW EXAMINED STUDIES PUBLISHED IN THE PUBMED, LILACS AND MEDLINE DATABASES WITHOUT RESTRICTION OF THE YEAR OF PUBLICATION. THE RESEARCH INVOLVED 16 DESCRIPTORS RELATED TO THE WORDS: YOGA, PAIN AND NEUROIMAGING METHODS. INCLUSION CRITERIA INVOLVED ONLY THE PUBLICATIONS AVAILABLE ONLINE, WITH FREE ACCESS AND WRITTEN IN ENGLISH. RESULTS: 2 CASE STUDIES AND 1 PILOT STUDY MET THE CRITERIA. YOGA MEDITATION PRACTICE INDUCES ANALGESIA PRIMARILY THROUGH ATTENUATION OF THE MEDIAL PAIN PERCEPTION SYSTEM INCLUDING THE ANTERIOR CINGULATE CORTEX AND INSULA REGIONS, AS WELL AS THE LATERAL SYSTEM INCLUDING THE SECONDARY SENSORY CORTEX AND THALAMUS. CONCLUSION: YOGA INDUCED ANALGESIA IS A POTENTIALLY IMPORTANT ADJUNCT TO CURRENT PAIN MANAGEMENT. THIS INTEGRATIVE REVIEW REVEALED THAT THERE IS A NEED FOR FURTHER RESEARCH THAT ANALYZES THE ENCEPHALIC REGIONS RELATED TO ANALGESIA INDUCED BY YOGA PRACTICE. 2018 11 2858 28 YOGA-BASED CARDIAC REHABILITATION: CURRENT PERSPECTIVES FROM RANDOMIZED CONTROLLED TRIALS IN CORONARY ARTERY DISEASE. CORONARY ARTERY DISEASE CARRIES A HIGH MORBIDITY AND MORTALITY WORLDWIDE, AND EXERCISE-BASED CARDIAC REHABILITATION PROGRAMMES PLAY A LARGE ROLE IN SECONDARY PREVENTION. EXERCISE-BASED REHABILITATION PROGRAMMES ARE EXPENSIVE, AND IN CERTAIN SUBGROUPS UPTAKE IS POOR. YOGA HAS BEEN SUGGESTED TO SHOW IMPROVEMENTS IN CARDIOVASCULAR HEALTH WHICH WOULD SUPPORT ITS USE IN CARDIAC REHABILITATION PROGRAMMES. WE CARRIED OUT A REVIEW OF CURRENT RANDOMIZED CONTROLLED TRIALS TO DETERMINE IF YOGA-BASED CARDIAC REHABILITATION LEADS TO REDUCED CARDIAC RISK FACTORS, AND IMPROVED PHYSIOLOGICAL AND PSYCHOLOGICAL OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE COMPARED TO STANDARD CARE. SIX RANDOMIZED CONTROLLED STUDIES WERE IDENTIFIED AFTER A MEDICAL DATABASE SEARCH, AND META-ANALYSIS WAS CARRIED OUT FOR THE DIFFERENT OUTCOMES. OVERALL, THE ADDITION OF YOGA TO STANDARD CARE RESULTED IN IMPROVED SUBJECTIVE FEELING OF CARDIAC HEALTH AND QUALITY OF LIFE. THERE WAS ALSO A TREND TOWARDS IMPROVEMENT IN LEFT VENTRICULAR SYSTOLIC FUNCTION. IMPROVEMENT IN CARDIAC RISK FACTORS, MACE AND PSYCHOLOGICAL HEALTH IN THIS COHORT HAS STILL TO BE PROVEN, BUT WAS NOT INFERIOR TO STANDARD OR ENHANCED CARE, AND THE BENEFITS BECAME MORE PRONOUNCED AT LONGER FOLLOW-UP. FUTURE STUDIES WITH LONGER FOLLOW-UP AND LARGER PATIENT NUMBERS WOULD AID IN ACCURATELY ASSESSING THE LONG-TERM BENEFIT OF YOGA-BASED REHABILITATION. 2021 12 2014 37 SUDARSHAN KRIYA YOGA: BREATHING FOR HEALTH. BREATHING TECHNIQUES ARE REGULARLY RECOMMENDED FOR RELAXATION, STRESS MANAGEMENT, CONTROL OF PSYCHOPHYSIOLOGICAL STATES, AND TO IMPROVE ORGAN FUNCTION. YOGIC BREATHING, DEFINED AS A MANIPULATION OF BREATH MOVEMENT, HAS BEEN SHOWN TO POSITIVELY AFFECT IMMUNE FUNCTION, AUTONOMIC NERVOUS SYSTEM IMBALANCES, AND PSYCHOLOGICAL OR STRESS-RELATED DISORDERS. THE AIM OF THIS STUDY WAS TO ASSESS AND PROVIDE A COMPREHENSIVE REVIEW OF THE PHYSIOLOGICAL MECHANISMS, THE MIND-BODY CONNECTION, AND THE BENEFITS OF SUDARSHAN KRIYA YOGA (SKY) IN A WIDE RANGE OF CLINICAL CONDITIONS. VARIOUS ONLINE DATABASES SEARCHED WERE MEDLINE, PSYCHINFO, EMBASE, AND GOOGLE SCHOLAR. ALL THE RESULTS WERE CAREFULLY SCREENED AND ARTICLES ON SKY WERE SELECTED. THE REFERENCES FROM THESE ARTICLES WERE CHECKED TO FIND ANY OTHER POTENTIALLY RELEVANT ARTICLES. SKY, A UNIQUE YOGIC BREATHING PRACTICE, INVOLVES SEVERAL TYPES OF CYCLICAL BREATHING PATTERNS, RANGING FROM SLOW AND CALMING TO RAPID AND STIMULATING. THERE IS MOUNTING EVIDENCE TO SUGGEST THAT SKY CAN BE A BENEFICIAL, LOW-RISK, LOW-COST ADJUNCT TO THE TREATMENT OF STRESS, ANXIETY, POST-TRAUMATIC STRESS DISORDER, DEPRESSION, STRESS-RELATED MEDICAL ILLNESSES, SUBSTANCE ABUSE, AND REHABILITATION OF CRIMINAL OFFENDERS. 2013 13 226 35 A SYSTEMATIC REVIEW OF RANDOMISED CONTROL TRIALS ON THE EFFECTS OF YOGA ON STRESS MEASURES AND MOOD. STRESS RELATED DISORDERS SUCH AS DEPRESSION AND ANXIETY ARE LEADING SOURCES OF DISABILITY WORLDWIDE, AND CURRENT TREATMENT METHODS SUCH AS CONVENTIONAL ANTIDEPRESSANT MEDICATIONS ARE NOT BENEFICIAL FOR ALL INDIVIDUALS. THERE IS EVIDENCE THAT YOGA HAS MOOD-ENHANCING PROPERTIES POSSIBLY RELATED TO ITS INHIBITORY EFFECTS ON PHYSIOLOGICAL STRESS AND INFLAMMATION, WHICH ARE FREQUENTLY ASSOCIATED WITH AFFECTIVE DISORDERS. HOWEVER THE BIOLOGICAL MECHANISMS VIA WHICH YOGA EXERTS ITS THERAPEUTIC MOOD-MODULATING EFFECTS ARE LARGELY UNKNOWN. THIS SYSTEMATIC REVIEW INVESTIGATES THE EFFECTS OF YOGA ON SYMPATHETIC NERVOUS SYSTEM AND HYPOTHALAMIC PITUITARY ADRENAL AXIS REGULATION MEASURES. IT FOCUSES ON STUDIES COLLECTING PHYSIOLOGICAL PARAMETERS SUCH AS BLOOD PRESSURE, HEART RATE, CORTISOL, PERIPHERAL CYTOKINE EXPRESSION AND/OR STRUCTURAL AND FUNCTIONAL BRAIN MEASURES IN REGIONS INVOLVED IN STRESS AND MOOD REGULATION. OVERALL THE 25 RANDOMISED CONTROL STUDIES DISCUSSED PROVIDE PRELIMINARY EVIDENCE TO SUGGEST THAT YOGA PRACTICE LEADS TO BETTER REGULATION OF THE SYMPATHETIC NERVOUS SYSTEM AND HYPOTHALAMIC-PITUITARY-ADRENAL SYSTEM, AS WELL AS A DECREASE IN DEPRESSIVE AND ANXIOUS SYMPTOMS IN A RANGE OF POPULATIONS. FURTHER RESEARCH IS WARRANTED TO CONFIRM THESE PRELIMINARY FINDINGS AND FACILITATE IMPLEMENTATION IN CLINICAL SETTINGS. 2015 14 1149 46 ENHANCEMENT OF CANCER STEM CELL SUSCEPTIBILITY TO CONVENTIONAL TREATMENTS THROUGH COMPLEMENTARY YOGA THERAPY: POSSIBLE CELLULAR AND MOLECULAR MECHANISMS. CANCER STEM CELLS (CSCS) ARE STEM-LIKE TUMOR POPULATIONS THAT ARE REPORTED TO CONTRIBUTE TOWARDS TUMOR GROWTH, MAINTENANCE AND RECURRENCE AFTER THERAPY. HYPOXIA INCREASES CSC FRACTION AND PROMOTES ACQUISITION OF A STEM-CELL-LIKE STATE. CANCER STEM CELLS ARE CRITICALLY DEPENDANT ON THE HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) FOR SURVIVAL, SELF-RENEWAL, TUMOR GROWTH AND MAINTENANCE OF THEIR UNDIFFERENTIATED PHENOTYPE. RECENT RESEARCHES SHOW THAT STAGE OF DIFFERENTIATION OF THE TUMOR CELLS IS PREDICTIVE OF THEIR SUSCEPTIBILITY TO NATURAL KILLER CELL (NK) CELL MEDIATED CYTOTOXICITY AND CANCER STEM CELLS ARE SIGNIFICANT TARGETS OF NK CELL CYTOTOXICITY. STUDIES ALSO SHOW THAT REVERSION OF TUMOR CELLS TO A LESS-DIFFERENTIATED PHENOTYPE CAN BE ACHIEVED BY BLOCKING NFKAPPAB. YOGA THERAPY (YOGIC LIFESTYLE MODIFICATIONS ENCOMPASSING PHYSICAL POSTURES, BREATHING PRACTICES, RELAXATION TECHNIQUES AND MEDITATIONS) IS KNOWN TO MODULATE NEURAL, ENDOCRINE AND IMMUNE FUNCTIONS AT THE CELLULAR LEVEL THROUGH INFLUENCING CELL CYCLE CONTROL, AGING, OXIDATIVE STRESS, APOPTOSIS AND SEVERAL PATHWAYS OF STRESS SIGNALING MOLECULES. YOGA THERAPY HAS ALSO BEEN SHOWN TO ENHANCE NATURAL KILLER CELL ACTIVITY AND MODULATE STRESS AND DNA DAMAGE IN BREAST CANCER PATIENTS RECEIVING RADIOTHERAPY. RECENT STUDY FOUND THAT BRIEF DAILY YOGIC MEDITATION MAY REVERSE THE PATTERN OF INCREASED NFKAPPAB-RELATED TRANSCRIPTION OF PRO-INFLAMMATORY CYTOKINES IN LEUKOCYTES. THUS, YOGA THERAPY HAS THE POTENTIAL TO REDUCE CANCER STEM CELL SURVIVAL, SELF -RENEWAL AND TUMOR GROWTH BY MODIFYING THE TUMOR MICRO-ENVIRONMENT THROUGH VARIOUS MECHANISMS SUCH AS; 1) REDUCING HIF-1 ACTIVITY BY ENHANCED OXYGENATION, 2) PROMOTING NK CELL ACTIVITY DIRECTLY (OR INDIRECTLY THROUGH DOWN REGULATING NFKAPPAB EXPRESSION), THEREBY ENHANCING NK CELL MEDIATED CSC LYSIS, AND 3) BY MINIMIZING THE ABERRANT EXPRESSIONS OR ACTIVITIES OF VARIOUS HORMONES, CYTOKINES, CHEMOKINES AND TUMOR SIGNALING PATHWAYS. YOGA THERAPY MAY HAVE A SYNERGISTIC EFFECT WITH CONVENTIONAL MODALITIES OF TREATMENT IN PREVENTING CANCER PROGRESSION AND RECURRENCES. 2012 15 1640 51 MOLECULAR SIGNATURE OF THE IMMUNE RESPONSE TO YOGA THERAPY IN STRESS-RELATED CHRONIC DISEASE CONDITIONS: AN INSIGHT. THE WORLD HEALTH ORGANIZATION DEFINES HEALTH AS COMPLETE WELL-BEING IN TERMS OF PHYSICAL, MENTAL AND SOCIAL, AND NOT MERELY THE ABSENCE OF DISEASE. TO ATTAIN THIS, INDIVIDUAL SHOULD ADAPT AND SELF-MANGE THE SOCIAL, PHYSICAL AND EMOTIONAL CHALLENGES OF LIFE. EXPOSURE TO CHRONIC STRESS DUE TO URBANIZATION, WORK STRESS, NUCLEAR FAMILY, POLLUTION, UNHEALTHY FOOD HABITS, LIFESTYLE, ACCIDENTAL DEATH IN THE FAMILY, AND NATURAL CALAMITIES ARE THE TRIGGERING FACTORS, LEADING TO HORMONAL IMBALANCE AND INFLAMMATION IN THE TISSUE. THE RELATIONSHIP BETWEEN STRESS AND ILLNESS IS COMPLEX; ALL CHRONIC ILLNESSES SUCH AS CARDIOVASCULAR DISEASE AND ASTHMA HAVE THEIR ROOT IN CHRONIC STRESS ATTRIBUTED BY INFLAMMATION. IN RECENT TIMES, YOGA THERAPY HAS EMERGED AS AN IMPORTANT COMPLEMENTARY ALTERNATIVE MEDICINE FOR MANY HUMAN DISEASES. YOGA THERAPY HAS A POSITIVE IMPACT ON MIND AND BODY; IT ACTS BY INCORPORATING APPROPRIATE BREATHING TECHNIQUES AND MINDFULNESS TO ATTAIN CONSCIOUS DIRECTION OF OUR AWARENESS OF THE PRESENT MOMENT BY MEDITATION, WHICH HELPS ACHIEVE HARMONY BETWEEN THE BODY AND MIND. STUDIES HAVE ALSO DEMONSTRATED THE IMPORTANT REGULATORY EFFECTS OF YOGA THERAPY ON BRAIN STRUCTURE AND FUNCTIONS. DESPITE THESE ADVANCES, THE CELLULAR AND MOLECULAR MECHANISMS BY WHICH YOGA THERAPY RENDERS ITS BENEFICIAL EFFECTS ARE INADEQUATELY KNOWN. A GROWING BODY OF EVIDENCE SUGGESTS THAT YOGA THERAPY HAS IMMUNOMODULATORY EFFECTS. HOWEVER, THE PRECISE MECHANISTIC BASIS HAS NOT BEEN ADDRESSED EMPIRICALLY. IN THIS REVIEW, WE HAVE ATTEMPTED TO HIGHLIGHT THE EFFECT OF YOGA THERAPY ON IMMUNE SYSTEM FUNCTIONING WITH AN AIM TO IDENTIFY IMPORTANT IMMUNOLOGICAL SIGNATURES THAT INDEX THE EFFECT OF YOGA THERAPY. TOWARD THIS, WE HAVE SUMMARIZED THE AVAILABLE SCIENTIFIC EVIDENCE SHOWING POSITIVE IMPACTS OF YOGA THERAPY. FINALLY, WE HAVE EMPHASIZED THE EFFICACY OF YOGA IN IMPROVING PHYSICAL AND MENTAL WELL-BEING. YOGA HAS BEEN A PART OF INDIAN CULTURE AND TRADITION FOR LONG; NOW, THE TIME HAS COME TO SCIENTIFICALLY VALIDATE THIS AND IMPLEMENT THIS AS AN ALTERNATIVE TREATMENT METHOD FOR STRESS-RELATED CHRONIC DISEASE. 2020 16 1675 31 OBESITY-RELATED INFLAMMATION & CARDIOVASCULAR DISEASE: EFFICACY OF A YOGA-BASED LIFESTYLE INTERVENTION. OBESITY IS A GLOBAL HEALTH BURDEN AND ITS PREVALENCE IS INCREASING SUBSTANTIALLY DUE TO CHANGING LIFESTYLE. CHRONIC ADIPOSITY IS ASSOCIATED WITH METABOLIC IMBALANCE LEADING TO DYSLIPIDAEMIA, DIABETES, HYPERTENSION AND CARDIOVASCULAR DISEASES (CVD). ADIPOSE TISSUE ACTS AS AN ENDOCRINE ORGAN RELEASING SEVERAL ADIPOCYTOKINES, AND IS ASSOCIATED WITH INCREASED LEVELS OF TISSUE AND CIRCULATING INFLAMMATORY BIOMOLECULES CAUSING VASCULAR INFLAMMATION AND ATHEROGENESIS. FURTHER, INFLAMMATION IS ALSO ASSOCIATED INDEPENDENTLY WITH OBESITY AS WELL AS CVD. KEEPING THIS IN VIEW, IT IS POSSIBLE THAT A REDUCTION IN WEIGHT MAY LEAD TO A DECREASE IN INFLAMMATION, RESULTING IN CVD RISK REDUCTION, AND BETTER MANAGEMENT OF PATIENTS WITH CVD. LIFESTYLE INTERVENTION HAS BEEN ENDORSED BY SEVERAL HEALTH AUTHORITIES IN PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. A YOGA-BASED LIFESTYLE INTERVENTION APPEARS TO BE A PROMISING OPTION IN REDUCING THE RISK FOR CVD AS WELL AS MANAGEMENT OF PATIENTS WITH CVD AS IT IS SIMPLE TO FOLLOW AND COST-EFFECTIVE WITH HIGH COMPLIANCE. THE EFFICACY OF SUCH LIFESTYLE INTERVENTION PROGRAMMES IS MULTIFACETED, AND IS ACHIEVED VIA REDUCTION IN WEIGHT, OBESITY-RELATED INFLAMMATION AND STRESS, THEREBY CULMINATING INTO RISK REDUCTION TOWARDS SEVERAL CHRONIC DISEASES INCLUDING CVD. IN THIS REVIEW, THE ASSOCIATION BETWEEN OBESITY-RELATED INFLAMMATION AND CVD, AND THE ROLE OF YOGA-BASED LIFESTYLE INTERVENTION IN PREVENTION AND MANAGEMENT OF CVD ARE DISCUSSED. 2014 17 1089 36 EFFECTS OF YOGA ON THE AUTONOMIC NERVOUS SYSTEM, GAMMA-AMINOBUTYRIC-ACID, AND ALLOSTASIS IN EPILEPSY, DEPRESSION, AND POST-TRAUMATIC STRESS DISORDER. A THEORY IS PROPOSED TO EXPLAIN THE BENEFITS OF YOGA PRACTICES IN DIVERSE, FREQUENTLY COMORBID MEDICAL CONDITIONS BASED ON THE CONCEPT THAT YOGA PRACTICES REDUCE ALLOSTATIC LOAD IN STRESS RESPONSE SYSTEMS SUCH THAT OPTIMAL HOMEOSTASIS IS RESTORED. IT IS HYPOTHESIZED THAT STRESS INDUCES (1) IMBALANCE OF THE AUTONOMIC NERVOUS SYSTEM (ANS) WITH DECREASED PARASYMPATHETIC NERVOUS SYSTEM (PNS) AND INCREASED SYMPATHETIC NERVOUS SYSTEM (SNS) ACTIVITY, (2) UNDERACTIVITY OF THE GAMMA AMINO-BUTYRIC ACID (GABA) SYSTEM, THE PRIMARY INHIBITORY NEUROTRANSMITTER SYSTEM, AND (3) INCREASED ALLOSTATIC LOAD. IT IS FURTHER HYPOTHESIZED THAT YOGA-BASED PRACTICES (4) CORRECT UNDERACTIVITY OF THE PNS AND GABA SYSTEMS IN PART THROUGH STIMULATION OF THE VAGUS NERVES, THE MAIN PERIPHERAL PATHWAY OF THE PNS, AND (5) REDUCE ALLOSTATIC LOAD. DEPRESSION, EPILEPSY, POST TRAUMATIC STRESS DISORDER (PTSD), AND CHRONIC PAIN EXEMPLIFY MEDICAL CONDITIONS THAT ARE EXACERBATED BY STRESS, HAVE LOW HEART RATE VARIABILITY (HRV) AND LOW GABAERGIC ACTIVITY, RESPOND TO PHARMACOLOGIC AGENTS THAT INCREASE ACTIVITY OF THE GABA SYSTEM, AND SHOW SYMPTOM IMPROVEMENT IN RESPONSE TO YOGA-BASED INTERVENTIONS. THE OBSERVATION THAT TREATMENT RESISTANT CASES OF EPILEPSY AND DEPRESSION RESPOND TO VAGAL NERVE STIMULATION CORROBORATES THE NEED TO CORRECT PNS UNDERACTIVITY AS PART OF A SUCCESSFUL TREATMENT PLAN IN SOME CASES. ACCORDING TO THE PROPOSED THEORY, THE DECREASED PNS AND GABAERGIC ACTIVITY THAT UNDERLIES STRESS-RELATED DISORDERS CAN BE CORRECTED BY YOGA PRACTICES RESULTING IN AMELIORATION OF DISEASE SYMPTOMS. THIS HAS FAR-REACHING IMPLICATIONS FOR THE INTEGRATION OF YOGA-BASED PRACTICES IN THE TREATMENT OF A BROAD ARRAY OF DISORDERS EXACERBATED BY STRESS. 2012 18 2486 54 YOGA AS AN INTEGRATIVE APPROACH FOR PREVENTION AND TREATMENT OF ORAL CANCER. DESPITE TREMENDOUS ADVANCEMENTS IN MEDICINE, THE NUMBER OF ORAL CANCER CASES CONTINUES TO INCREASE, AND THE NEED FOR INTEGRATING ALTERNATE MEDICINE OR ADOPTING AN INTEGRATIVE APPROACH HAS BECOME A COMPELLING COST-EFFECTIVE REQUIREMENT FOR THE MANAGEMENT AND TREATMENT OF DISEASES. CONVENTIONAL TREATMENT OF ORAL CANCER INVOLVES SURGERY FOLLOWED BY RADIOTHERAPY WITH OR WITHOUT CHEMOTHERAPY WHICH CAUSES SEVERAL COMPLICATIONS INCLUDING POOR QUALITY OF LIFE AND HIGH CHANCES OF RECURRENCE OF CANCER. ORAL CANCER IS OFTEN LINKED WITH OBESITY WHICH IS MAJOR RISK FACTORS IN OTHER CANCERS. APART FROM OBESITY, ORAL CANCER IS THOUGHT TO HAVE AN INVERSE RELATION WITH NEURODEGENERATIVE DISORDERS PRESUMABLY BECAUSE CELL DEATH DECREASES IN THE FORMER CASE AND INCREASES IN THE LATTER. ANCIENT MIND-BODY TECHNIQUES SUCH AS YOGA HAVE NOT BEEN ADEQUATELY TESTED AS A TOOL TO SYNERGIZE THE CELLULAR EQUILIBRIUM PERTAINING TO THE TREATMENT OF ORAL CANCER. NERVE GROWTH FACTOR (NGF), TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA), AND INTERLEUKIN-6 (IL-6) ARE AMONG THE EARLY EXPERIMENTAL CELLULAR BIOMARKERS THAT MAY BE USED TO PROBE THE MODULATION OF ORAL CANCER, OBESITY, AND NEURODEGENERATIVE DISORDERS. YOGA HAS BEEN REPORTED TO INFLUENCE THESE MOLECULES IN HEALTHY INDIVIDUALS BUT WHETHER THEIR EXPRESSION CAN BE ALTERED IN PATIENTS OF ORAL CANCER BY YOGA INTERVENTION IS THE SUBJECT OF THIS RESEARCH BEING DISCUSSED IN THIS REVIEW ARTICLE. THEREFORE, THE PRESENT ARTICLE NOT ONLY REVIEWS THE CURRENT STATUS OF RESEARCH STUDIES IN ORAL CANCER, OBESITY, AND NEURODEGENERATIVE DISORDERS BUT ALSO HOW THESE ARE LINKED TO EACH OTHER AND WHY THE INVESTIGATIONS OF THE PUTATIVE NGF PATHWAY, INVOLVING TNF-ALPHA AND IL-6, COULD PROVIDE USEFUL CLUES TO UNDERSTAND THE MOLECULAR EFFECTS BROUGHT ABOUT BY YOGA INTERVENTION IN SUCH PATIENTS. 2018 19 2416 36 YOGA AND MEDITATION IN CARDIOVASCULAR DISEASE. YOGA IS A HOLISTIC MIND-BODY INTERVENTION AIMED AT PHYSICAL, MENTAL, EMOTIONAL AND SPIRITUAL WELL BEING. SEVERAL STUDIES HAVE SHOWN THAT YOGA AND/OR MEDITATION CAN CONTROL RISK FACTORS FOR CARDIOVASCULAR DISEASE LIKE HYPERTENSION, TYPE II DIABETES AND INSULIN RESISTANCE, OBESITY, LIPID PROFILE, PSYCHOSOCIAL STRESS AND SMOKING. SOME RANDOMIZED STUDIES SUGGEST THAT YOGA/MEDITATION COULD RETARD OR EVEN REGRESS EARLY AND ADVANCED CORONARY ATHEROSCLEROSIS. A RECENT STUDY SUGGESTS THAT TRANSCENDENTAL MEDITATION MAY BE EXTREMELY USEFUL IN SECONDARY PREVENTION OF CORONARY HEART DISEASE AND MAY REDUCE CARDIOVASCULAR EVENTS BY 48% OVER A 5-YEAR PERIOD. ANOTHER SMALL STUDY SUGGESTS THAT YOGA MAY BE HELPFUL IN PREVENTION OF ATRIAL FIBRILLATION. HOWEVER, MOST STUDIES HAVE SEVERAL LIMITATIONS LIKE LACK OF ADEQUATE CONTROLS, SMALL SAMPLE SIZE, INCONSISTENCIES IN BASELINE AND DIFFERENT METHODOLOGIES, ETC. AND THEREFORE LARGE TRIALS WITH IMPROVED METHODOLOGIES ARE REQUIRED TO CONFIRM THESE FINDINGS. HOWEVER, IN VIEW OF THE EXISTING KNOWLEDGE AND YOGA BEING A COST-EFFECTIVE TECHNIQUE WITHOUT SIDE EFFECTS, IT APPEARS APPROPRIATE TO INCORPORATE YOGA/MEDITATION FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE. 2014 20 1669 41 NEUROPHYSIOLOGICAL AND NEUROCOGNITIVE MECHANISMS UNDERLYING THE EFFECTS OF YOGA-BASED PRACTICES: TOWARDS A COMPREHENSIVE THEORETICAL FRAMEWORK. DURING RECENT DECADES NUMEROUS YOGA-BASED PRACTICES (YBP) HAVE EMERGED IN THE WEST, WITH THEIR AIMS RANGING FROM FITNESS GAINS TO THERAPEUTIC BENEFITS AND SPIRITUAL DEVELOPMENT. YOGA IS ALSO BEGINNING TO SPARK GROWING INTEREST WITHIN THE SCIENTIFIC COMMUNITY, AND YOGA-BASED INTERVENTIONS HAVE BEEN ASSOCIATED WITH MEASUREABLE CHANGES IN PHYSIOLOGICAL PARAMETERS, PERCEIVED EMOTIONAL STATES, AND COGNITIVE FUNCTIONING. YBP TYPICALLY INVOLVE A COMBINATION OF POSTURES OR MOVEMENT SEQUENCES, CONSCIOUS REGULATION OF THE BREATH, AND VARIOUS TECHNIQUES TO IMPROVE ATTENTIONAL FOCUS. HOWEVER, SO FAR LITTLE IF ANY RESEARCH HAS ATTEMPTED TO DECONSTRUCT THE ROLE OF THESE DIFFERENT COMPONENT PARTS IN ORDER TO BETTER UNDERSTAND THEIR RESPECTIVE CONTRIBUTION TO THE EFFECTS OF YBP. A CLEAR OPERATIONAL DEFINITION OF YOGA-BASED THERAPEUTIC INTERVENTIONS FOR SCIENTIFIC PURPOSES, AS WELL AS A COMPREHENSIVE THEORETICAL FRAMEWORK FROM WHICH TESTABLE HYPOTHESES CAN BE FORMULATED, IS THEREFORE NEEDED. HERE WE PROPOSE SUCH A FRAMEWORK, AND OUTLINE THE BOTTOM-UP NEUROPHYSIOLOGICAL AND TOP-DOWN NEUROCOGNITIVE MECHANISMS HYPOTHESIZED TO BE AT PLAY IN YBP. 2015